Related Experiment Videos
[The complement system in hepatopathies]
Annales De Medecine Interne
|January 1, 1985
Insights
Patients with liver cirrhosis often have low serum complement due to reduced synthesis and increased consumption. This deficiency elevates infection risk in these patients.
Area of Science:
- Immunology
- Hepatology
- Biochemistry
Context:
- Liver cirrhosis is a significant global health issue.
- Patients with cirrhosis exhibit a higher susceptibility to infections.
- Serum complement levels are frequently diminished in cirrhosis patients.
Purpose:
- To investigate the mechanisms behind low serum complement in liver cirrhosis.
- To understand the role of complement deficiency in infection risk.
Summary:
- Low serum complement in cirrhosis results from impaired synthesis of complement components and regulatory proteins.
- Increased consumption of complement due to systemic activation further depletes serum levels.
- This acquired complement deficit is a key factor in the heightened risk of infection observed in cirrhosis.
Impact:
- Highlights the clinical significance of complement system dysregulation in liver disease.
- Provides insights into the pathophysiology of infection susceptibility in cirrhosis.
- Suggests potential therapeutic targets for managing infections in liver cirrhosis patients.
Abstract:
Low serum complement is often observed in cirrhosis of the liver. This is the result of two mechanisms: a failure to synthesise a certain number of components and regulatory proteins of complement, and an increased consumption due to activation of the complement system. This acquired deficit in complement contributes to the increased risk of infection in patients with cirrhosis.